Q Fever Risk Management SWMS
Q fever prevention for workers exposed to livestock, abattoirs, veterinary practice, and rural environments — pre-employment serology, vaccination, and PPE for Coxiella burnetii.
SWMS variants reference your state’s WHS legislation. Instant download after payment.
Q fever risk management covers the prevention of Q fever in workers exposed to livestock, abattoirs, veterinary practice, and rural environments — pre-employment serology, vaccination, and personal protective equipment for Coxiella burnetii. Q fever is a serious bacterial zoonosis caused by Coxiella burnetii, an organism shed in the birth products, urine, faeces, and milk of infected animals (particularly cattle, sheep, and goats) that survives in the environment and is readily inhaled in contaminated dust and aerosols. The work is not classified as High-Risk Construction Work, so this product sits at the $199 price as a specialist biological-agents product, but the controls it documents are essential for any PCBU whose workers face credible Coxiella burnetii exposure.
The defining feature of Q fever prevention is that an effective vaccine exists but must be preceded by screening — a person already immune or previously exposed should not be vaccinated, so pre-vaccination serology and skin testing are integral to the programme. The control framework therefore combines a medical pathway (screening, vaccination, and a register) with the workplace controls of dust and aerosol suppression, hygiene, and PPE. The work follows the framework for managing biological hazards, the NHMRC Q Fever guidance, and the relevant state Q fever programmes, with the National Q Fever Vaccination Program and the Queensland Q Fever Management Program among the key references where applicable.
This SWMS is jurisdiction-neutral within Australia and written to the model WHS framework. Victoria operates under the Occupational Health and Safety Act 2004 and OHS Regulations 2017 — check the VIC-specific variant for the local equivalents of the duties and codes cited here.
Hazards identified
10 hazards covered, sorted by priority.
Acute Q fever — high fever, severe headache, and pneumonia — from inhaling the organism in dust and aerosols from infected animals and contaminated environments.
High-dose Coxiella burnetii exposure, as birth products and fluids carry very high organism loads, causing acute infection.
Chronic Q fever (endocarditis) and post-Q-fever fatigue syndrome causing long-term, sometimes life-threatening, ill health following infection.
Infection from handling hides, wool, and products carrying the organism, which survives in the environment for long periods.
Infection at a distance from the source, as the organism is hardy, survives in soil and dust, and can be carried on the wind.
Severe local and systemic reaction if a person with prior exposure or immunity is vaccinated without pre-vaccination screening.
Infection from aerosols generated during slaughter, dressing, and rendering operations in an abattoir environment.
Secondary exposure of household members from the organism carried home on contaminated clothing and footwear.
Progression to severe or chronic disease if early Q fever is not recognised and treated promptly in an exposed worker.
Infection of visitors, contractors, and new workers who enter the environment without screening and vaccination.
Control measures
Hierarchy-of-controls order: elimination → substitution → isolation → engineering → administrative → PPE.
- 1Implement a Q fever vaccination programme as the primary control for workers with credible Coxiella burnetii exposure, preceded by mandatory pre-vaccination screening — serology and skin testing — so that only suitable, non-immune workers are vaccinated, consistent with the NHMRC Q Fever guidance.
- 2Maintain a Q fever register of workers' screening, vaccination, and immune status (such as through the National Q Fever Register where applicable), and do not place an unscreened, unvaccinated worker in a high-exposure role.
- 3Control dust and aerosol generation at the source — wetting, ventilation, and process controls in animal-handling, slaughter, and dressing areas — to reduce the airborne organism load.
- 4Apply heightened controls and restricted access during high-risk activities, particularly animal birthing and birth-product handling, which carry very high organism loads.
- 5Manage hides, wool, and animal products as potentially contaminated, with handling and storage controls that limit aerosol generation and exposure.
- 6Provide hygiene facilities and enforce hygiene discipline — handwashing, no eating in work areas, and prompt cleaning — to control contact and take-home exposure.
- 7Provide a change and laundering regime for work clothing and footwear so contamination is not carried home to household members.
- 8Educate workers to recognise the early symptoms of Q fever and provide a pathway for prompt medical assessment and treatment of a suspected infection.
- 9Screen and, where suitable, vaccinate visitors, contractors, and new workers before they enter high-exposure environments, and manage access for those who cannot be vaccinated.
- 10Provide PPE as a supplementary control — respiratory protection rated for the bioaerosol (fit-tested), protective clothing, gloves, and eye protection — for high-exposure tasks, recognising that vaccination is the primary control.
- 11Consult workers on the Q fever risk and the screening and vaccination programme, and brief every worker on the SWMS, the exposure controls, and the medical pathway before work in an exposure environment.
- 12Review the programme and the register periodically, and after any suspected case, to confirm the controls and immune coverage remain effective.
Applicable Codes of Practice
Becomes legally binding under Section 26A of the WHS Act from 1 July 2026 in the relevant parts. Governs the assessment and control of the biological-agent exposure to Coxiella burnetii in the workplace.
Provides the authoritative Australian medical basis for Q fever screening, vaccination, and the pre-vaccination serology and skin-testing requirement that underpins the programme.
Safety in laboratories — Microbiological safety and containment. Informs the biological exposure controls and containment principles applied to Coxiella burnetii handling and exposure.
Becomes legally binding under Section 26A from 1 July 2026. Governs the risk-management process — identify, assess, control, review — applied to the Q fever biological hazard.
Selection, use and maintenance of respiratory protective equipment. Drives the selection and fit-testing of respiratory protection for the Coxiella burnetii bioaerosol during high-exposure tasks.
Respiratory protective devices. Specifies the performance requirements for the respirators used to protect against the bioaerosol exposure.
Who this is for
- →Abattoir and meat-processing operators managing Q fever risk for their workforce.
- →Livestock producers and saleyards with workers exposed to cattle, sheep, and goats.
- →Veterinary practices and animal-health workers handling potentially infected animals.
- →Agricultural and rural employers whose workers face credible Coxiella burnetii exposure.
- →Contractors and labour providers placing workers into livestock and abattoir environments.
What you receive
- ✓Editable Microsoft Word .docx — open in Word or Google Docs, drop in your company logo and ABN.
- ✓State-specific variant matched to the jurisdiction selected at checkout (NSW, VIC, QLD, SA, WA, TAS, NT, or ACT).
- ✓All 10 hazards risk-assessed with inherent and residual ratings against a documented control set.
- ✓A screening-and-vaccination programme referenced to the NHMRC Q Fever guidance and the biological-agents framework.
- ✓Workplace exposure controls referenced to AS/NZS 2243.3, AS/NZS 1715, and the model codes.
- ✓CIH-reviewed content written to be defended in front of an industry auditor or a SafeWork inspector.
- ✓Instant download on payment, with a re-download window so you can retrieve the file again if needed.
- ✓Sign-on register and review-log structure ready for site-specific completion by the PCBU.
Worked example
An abattoir in regional Queensland processing cattle and sheep manages Q fever as a priority biological hazard for its workforce, since slaughter and dressing operations generate aerosols carrying Coxiella burnetii. The operator implements this SWMS, selecting the QLD variant and drawing on the Queensland Q Fever Management Program and the National Q Fever Vaccination Program. The cornerstone control is the vaccination programme: every new worker entering a high-exposure role undergoes mandatory pre-vaccination screening — serology and a skin test — so that only suitable, non-immune workers are vaccinated, because vaccinating an already-immune person risks a severe reaction. The screening, vaccination, and immune status of each worker are recorded in a Q fever register, and no unscreened, unvaccinated worker is placed in a high-exposure role. Alongside the medical pathway, dust and aerosol generation is controlled at the source in the slaughter and dressing areas, hides and products are handled as potentially contaminated, and a change-and-laundering regime prevents take-home contamination to workers' families. Workers are educated to recognise early Q fever symptoms and have a pathway for prompt medical assessment. Visitors and contractors are screened before entering high-exposure areas. Respiratory protection is provided as a supplement for high-exposure tasks, with vaccination remaining the primary control. The programme is reviewed periodically and after any suspected case. The workforce maintains high immune coverage with no recorded acute Q fever case, and the signed SWMS and the register are retained for the operator's health-and-safety records.
Related legislation
- Work Health and Safety Act 2011 (NSW) — Sections 19 (primary duty of care), 28 (worker duties), 46-49 (consultation)
- Work Health and Safety Regulation 2017 (NSW) — Sections 32-38 (managing risks), 49-50 (health monitoring), and the biological-agents provisions
- NHMRC Q Fever guidance and the Australian Immunisation Handbook — screening and vaccination
- AS/NZS 2243.3:2022 — Safety in laboratories, Part 3: Microbiological safety and containment
- AS/NZS 1715:2009 — Selection, use and maintenance of respiratory protective equipment
Frequently asked questions
Why is this a $199 product if it is not High-Risk Construction Work?
Q fever risk management is a specialist biological-agents product priced at $199 for its depth and the criticality of the controls, even though it is not HRCW and so includes no Reg 291 breakdown. The work is not construction work and does not meet the HRCW triggers, but the consequences of inadequate Q fever control are severe, so the SWMS documents a full screening, vaccination, and exposure-control programme.
Why must workers be screened before vaccination?
An effective Q fever vaccine exists, but a person who is already immune or previously exposed can have a severe reaction if vaccinated. Pre-vaccination screening — serology and a skin test — identifies who can safely be vaccinated, so screening is integral to the programme rather than optional. The SWMS makes mandatory pre-vaccination screening the gateway to vaccination, consistent with the NHMRC Q Fever guidance.
Is vaccination enough on its own?
Vaccination is the primary control, but the SWMS also requires workplace controls — dust and aerosol suppression at the source, heightened controls during high-risk birthing work, hygiene, a change-and-laundering regime, and supplementary respiratory protection for high-exposure tasks. These reduce the organism load and protect workers who cannot be vaccinated and household members from take-home exposure, so vaccination and the workplace controls work together.
Which animals and activities carry the highest risk?
Cattle, sheep, and goats are the main reservoirs, and the organism is shed in very high loads in birth products and fluids. Animal birthing and birth-product handling, and slaughter and dressing operations, are the highest-risk activities because they generate high-load aerosols. The SWMS applies heightened controls and restricted access to these activities specifically.
Does the programme cover visitors and contractors?
Yes. Visitors, contractors, and new workers who enter a high-exposure environment without screening and vaccination are at risk, so the SWMS requires them to be screened and, where suitable, vaccinated before entry, and managed if they cannot be vaccinated. This closes the gap that arises when a vaccinated permanent workforce hosts unprotected visitors in the same environment.